Ngoc-Thu Phung
Family · Broken Arrow, OKNPI 1649895020
Payments from drug & device makers
Across 288 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Neurocrine Biosciences, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$827
- Teva Pharmaceuticals USA, Inc.$827
- AbbVie$534
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$170
- plus $616 from 8 others
What the payments were for
- Food & beverage$5,66297%
- Education$1743%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 69 | $1,723 |
| Neurocrine Biosciences, Inc. | 109 | $1,140 |
| Otsuka America Pharmaceutical, Inc. | 38 | $827 |
| Teva Pharmaceuticals USA, Inc. | 18 | $827 |
| AbbVie | 19 | $534 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $170 |
| Supernus Pharmaceuticals, Inc. | 3 | $161 |
| Alkermes, Inc. | 8 | $153 |
| E.r. Squibb & Sons, L.L.C. | 7 | $126 |
| Lundbeck LLC | 4 | $68 |
| Braeburn Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Indivior Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$816
- INVEGA TRINZA$413
- Austedo XR$356
- VRAYLAR$242
- REXULTI$238
- QELBREE$125
- ABILIFY ASIMTUFII$123
- ABILIFY MAINTENA$123
- UZEDY$122
- AUSTEDO$115
How this compares
$5,836 in reported general payments places this provider in the 95th percentile of 2,026 family providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 52 | $163,816 |
| Abilify MaintenaAripiprazole | 16 | $38,768 |
| VraylarCariprazine Hcl | 18 | $24,430 |
| Asenapine Maleate | 13 | $2,462 |
| Chlorpromazine Hcl | 15 | $1,510 |
| Aripiprazole | 32 | $891 |
| Haloperidol | 23 | $739 |
| Quetiapine Fumarate | 55 | $528 |
| Prazosin Hcl | 37 | $446 |
| Trazodone Hcl | 74 | $416 |
| Zolpidem Tartrate | 52 | $384 |
| Duloxetine Hcl | 18 | $377 |
| Amitriptyline Hcl | 11 | $372 |
| Buspirone Hcl | 22 | $368 |
| Gabapentin | 36 | $362 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $1,723 | $163,81652 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $827 | $38,76816 claims |
| AbbVieVraylar | $534 | $24,43018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,026 family providers in Oklahoma.
Other family in Broken Arrow
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Shelby WrightStillwater$17K
- Brandy ReevesNorman$17K
- Amanda OblanderYukon$17K
- Julia John SamuelOklahoma City$17K
- Jillian OakleafTulsa$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.